Regenerative medicineNov 24, 2025

Stem cells may improve treatment for Clouston syndrome, a rare skin and hair disorder

Regenerative Health Weekly Brief ↗PubMed ↗DOI ↗

Updated Jan 3, 2026

Abstract

Clouston syndrome presents significant challenges due to its multisystemic manifestations and limited therapeutic options.

Stem cells, including mesenchymal stem cells, epidermal stem cells, and induced pluripotent stem cells, may help regenerate skin, hair, and nails.
Gene-editing technologies like CRISPR-Cas9 could correct pathogenic mutations associated with the syndrome.
Emerging techniques in tissue engineering and 3D bioprinting are being explored for creating patient-specific bioengineered constructs.
Clinical trials in related genetic disorders suggest the feasibility of these approaches in potentially improving patient outcomes.
Challenges such as immune rejection, ethical concerns, and scalability of stem cell production may hinder progress.

Simplified

Clouston syndrome is a rare autosomal dominant form of hidrotic ectodermal dysplasia that presents significant challenges due to its multisystemic manifestations and limited therapeutic options. This review explores the functional role of stem cells in the treatment and management of Clouston syndrome, highlighting advancements in regenerative medicine and stem cell therapy. Stem cell types such as mesenchymal stem cells (MSCs), epidermal stem cells (EpSCs), and induced pluripotent stem cells (iPSCs) have shown promise in regenerating ectodermal derivatives like skin, hair, and nails. Gene-editing technologies, including Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR-Cas9), can correct pathogenic mutations in thegene. Emerging techniques in tissue engineering and three dimensional (3D) bioprinting are also discussed, focusing on their potential to create patient-specific, bioengineered constructs. Clinical trials in related genetic disorders provide evidence for the feasibility of these approaches in improving patient outcomes. However, challenges such as immune rejection, ethical concerns, and stem cell production scalability remain barriers. Addressing these issues requires interdisciplinary collaboration, sustained funding, and targeted research. This review underscores the transformative potential of regenerative medicine. It highlights the need for continued efforts to develop curative strategies for treatment, integrating stem cell-based therapies, gene editing, and bioengineering. GJB6

Full Text

Full text is available at the source.

View Full Text ↗

Funding

Competing interests

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

PubMed

Stem cells may improve treatment for Clouston syndrome, a rare skin and hair disorder

Abstract

Full Text

Funding

Competing interests

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week: